In the BioHarmony Drug Report Database
Carboprost tromethamine
Hemabate (carboprost tromethamine) is a small molecule pharmaceutical. Carboprost tromethamine was first approved as Hemabate on 1982-01-01. It is used to treat cystitis, fetal death, incomplete abortion, and postpartum hemorrhage in the USA.
Trade Name
|
Hemabate |
---|---|
Common Name
|
carboprost tromethamine |
ChEMBL ID
|
CHEMBL1237105 |
Indication
|
cystitis, fetal death, incomplete abortion, postpartum hemorrhage |
Drug Class
|
Prostaglandins |
Image (chem structure or protein)